Bioethics International’s (BEI) mission is to advance patient and global public health by improving the ethics, transparency, patient-centricity, and governance of healthcare innovation and delivery.
They focus on the ethics and governance of how medicines, vaccines, biologics, and devices are researched, developed, marketed, and made accessible to patients domestically and globally. They focus on the issues that matter to patients the most.
To accomplish their mission, they:
Map ethics concerns, about healthcare innovation and delivery that pose patient or global public health risks
Identify best practices and develop standards, that can reasonably address perceived system problems
Benchmark the performance of medicines, vaccines, and companies by standards and best practices
Create reforms to help fix system problems that pose patient or global public health risks
Their work addresses the roles of pharmaceutical companies, medical societies, hospitals, IRBs, pharmacy and therapeutics (P&T) committees, pharmacy benefits mangers (PBMs), patient advocacy groups, investors, contract research organizations (CRO’s), universities, and scientists in advancing patient and global public health and access to medicines.
BEI is a 501c3 public charity founded by Dr. Jennifer E. Miller in 2005, incorporated in the State of New York in 2006, and granted public charity status by the IRS in 2007.
Where is Bioethics International